Page 23 - Compugen News Today

אירודרום  מטפסת כ-5% בהמשך לדיווח על רכישת חברת FlyTech, המתמחה במתן שירותים ופתרונות אוויריים מתקדמים בשוק האזרחי. בכוונת אירודרום לרכז תחתיה את כל פע×...

Compugen Announces Updated Data from Phase 1 Study of COM701, First- in-Class Anti-PVRIG, at the ASCO 2021 Annual Meeting Font : A-A+ Data show ongoing durable responses beyond one year in monotherapy and in combination with Opdivo® in heavily pre-treated patients including one patient with prior progression on Opdivo® HOLON, Israel, June 8, 2021 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, presented ...

Compugen Management to Discuss COM701 Data Presented at ASCO at Event Hosted by Truist Securities - read this article along with other careers information, tips and advice on BioSpace

by Tyler Durden Thursday, May 27, 2021 - 03:00 PM If you had a sneaking suspicion that Wall Street was starting to bet against the "untouchable" Cathie Wood, as we did over the last couple months, you were right. Today it was revealed that "about two dozen investment advisers" that included Balyasny Asset Management and a unit of Blackstone bought put options on ARKs Innovation ETF during the first quarter. Blackstone bought puts on 1.3 million ARKK shares and Balyasny acquired puts on 436,...

by Tyler Durden Monday, May 24, 2021 - 05:45 AM We have been harping on Cathie Woods apparent "strategy" of selling liquid tech names in order to rotate into smaller, more "speculative" names, in her ARK ETFs for the better part of 2021.  While she has been able to ride out the "volatility" in the NASDAQ (read: the NASDAQ is literally only about 5% off highs) using this strategy so far, people in the mainstream media are starting to notice her allocation decisions and are keeping a close eye A...

Ark Investment Management no longer holds a stake bigger than 20% in any stock, down from three companies in February.

Data Bridge Market Research has added a new report titled Global Biosimulation Market Size, Share, Growth, Industry Trends and Forecast to 2028 in its database, which describes a systematic image of the market and provides an in-depth explanation of the various factors that are expected to drive the market growth. A...

Operator Ladies and gentlemen, thank you for joining us today. Welcome to Compugens First Quarter 2021 Results Conference Call. [Operator Instructions] With us from Compugen are Dr. Anat Cohen-Dayag; Ari Krashin, CFO and COO; and Dr. Henry Adewoye, Chief Medical Officer, who will be available for questions at the end of the call. Before we begin, I would like to read the following regarding forward-looking statements. During the course of this conference call, the company may make projections o...

Despite the continued rocket fire on Israel, the main market indices rose today, leaving the Tel Aviv 35 Index down just 0.5% for the week.

Compugen: Q1 Earnings Snapshot Last Updated May 13, 2021 at 7:28 am EDT HOLON, Israel (AP) _ Compugen Ltd. (CGEN) on Thursday reported a loss of $9.9 million in its first quarter. On a per-share basis, the Holon, Israel-based company said it had a loss of 12 cents. The results matched Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was also for a loss of 12 cents per share. Compugen shares have dropped 43% since the beginning of the year. The...